Zevra Therapeutics, Inc.
ZVRA
$12.23
-$0.45-3.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.75M | 37.89M | 12.17M | -544.00K | 74.71M |
| Total Depreciation and Amortization | 364.00K | 368.00K | 362.00K | 392.00K | 1.65M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.84M | -41.70M | 3.04M | 7.19M | -72.67M |
| Change in Net Operating Assets | -926.00K | 9.59M | -10.05M | -2.33M | -7.29M |
| Cash from Operations | 17.03M | 6.14M | 5.52M | 4.71M | -3.60M |
| Capital Expenditure | -217.00K | -35.00K | 31.00K | -554.00K | -213.00K |
| Sale of Property, Plant, and Equipment | 4.96M | 43.98M | -141.00K | 589.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.71M | 35.68M | 337.00K | -4.61M | 12.15M |
| Cash from Investing | 31.45M | 79.62M | 227.00K | -4.58M | 11.93M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -60.09M | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 1.59M | 9.92M | 2.55M | 6.53M | 1.38M |
| Repurchase of Common Stock | -- | -2.64M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.59M | -52.80M | 2.55M | 6.53M | 1.38M |
| Foreign Exchange rate Adjustments | -342.00K | 233.00K | -322.00K | 64.00K | 658.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 49.73M | 33.19M | 7.97M | 6.73M | 10.37M |